multiple myeloma
BostonGene, Mount Sinai Partner on Multiple Myeloma Precision Oncology Study
The study will use BostonGene's assays, including whole-exome and whole-transcriptome sequencing, to inform patients' clinical care and advance drug development.
BostonGene, Sylvester Comprehensive Cancer Center Partner on Hematologic Cancer Molecular Subtyping
Researchers will compare traditional tumor profiling methods such as FISH and cytogenetics to BostonGene's AI-powered molecular and immune profiling platform.
Predicta Biosciences Raises $5.2M in Seed Round
The funding will be used to expand the company's team and build a CLIA laboratory and workflow for sequencing and bioinformatics.
Researchers call for more data sharing from single-cell RNA sequencing studies to help validate machine learning precision medicine tools.
Variant Screening Tool Flags Possible Pathogenic Germline Variants in Multiple Myeloma Patients
Premium
The tool developed by Mount Sinai researchers is designed to identify variants associated with heritable cancer risk within somatic genetic sequencing results.
May 5, 2022
May 6, 2021
Natera Q1 Revenues Grow 62 Percent
Feb 26, 2020